Enterra Therapy System Commercialization
Chronic intractable nausea & vomiting due to gastroparesis (diabetic or idiopathic)
Key Facts
About Enterra Medical
Enterra Medical is a private medical device company commercializing the Enterra Therapy System, a humanitarian use device (HUD) for treating chronic, medication-resistant nausea and vomiting due to gastroparesis. The company originated from Medtronic's technology, which received FDA approval in 2000, and was established as an independent entity to drive innovation and support for this underserved patient population. With over 15,000 devices implanted, Enterra operates in a niche but significant market with limited direct device competition, though it faces challenges related to the device's humanitarian designation, which means effectiveness is not proven. Its strategy revolves around patient and physician education, provider network development, and leveraging real-world evidence to support therapy adoption.
View full company profile